Evidence map›Paper›PMID 33731607›Full record

ArticleCritical care medicine2021

The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients.

Ishaq Lat, Craig M Coopersmith, Daniel De Backer, Research Committee of the Surviving Sepsis Campaign, Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows, Co-chair, Atlanta, GA, Co-chair, Brussels, Belgium, Manhasset, NY, Consultant, Seattle, WA, Barcelona, Spain and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Critical care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Observational
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Global Burden of Sepsis and Septic Shock.Epidemiologia (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. [Pharmacological therapy of circulatory shock].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Ishaq LatDepartment of Pharmacy, Shirley Ryan AbilityLab, Chicago, IL.
Craig M CoopersmithDepartment of Surgery and Emory Critical Care Center, Emory University, Atlanta, GA.
Daniel De BackerDepartment of Intensive Care, Chirec Hospitals, Université Libre de Bruxelles, Brussels, Belgium.
Research Committee of the Surviving Sepsis Campaign
Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows
Co-chair, Atlanta, GA
Co-chair, Brussels, Belgium
Manhasset, NY
Consultant, Seattle, WA
Barcelona, Spain
San Francisco, CA
Pune, India
Utrecht, the Netherlands
Chicago, IL
Sao Paulo, Brazil
Atlanta, GA
Dublin, Ireland
New York, NY
Consultant, London, United Kingdom.
Research Committee of the Surviving Sepsis Campaign and Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows and Co-chair, Atlanta, GA and Co-chair, Brussels, Belgium and Manhasset, NY and Consultant, Seattle, WA and Barcelona, Spain and San Francisco, CA and Pune, India and Utrecht, the Netherlands and Chicago, IL and Sao Paulo, Brazil and Atlanta, GA and Dublin, Ireland and New York, NY and Consultant, London, United Kingdom.
Université Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveExpand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine. DATA SOURCES: Original article, literature search. STUDY SELECTION: Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy. DATA EXTRACTION: None. DATA SYNTHESIS: None.

conclusionIn the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.

Indexed as

Practice Guidelines as TopicSeverity of Illness IndexAdultCritical CareEvidence-Based MedicineFemaleFluid TherapyGuidelines as TopicHumansMaleSepsisVasoconstrictor AgentsVasoconstrictor Agents

Identifiers

PMID33731607
PMCPMC7963440
OpenAlexW3134887812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.